Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Some morphologic parameters have been studied to help predict the BRAFV600E mutation using cytopathologic specimens, which can indicate which nodules should undergo further testing. The aim of this study was to investigate the value of cytomorphologic parameters to predict the BRAFV600E mutation in nodules read as "suspicious for malignancy" on cytology. This study included 142 resected nodules which were diagnosed as "suspicious for malignancy" on cytology in 142 patients. At our institution, BRAFV600E mutation analysis was performed at the request of the referring clinicians based on the clinical features of the patients, or the judgment of the radiologists performing US-FNA because suspicious US features were observed on the targeted nodule during this study period. Cytology smears were re-reviewed to assess the presence and amount of polygonal eosinophilic (plump) cells and microfollicles, and the presence of intranuclear pseudoinclusions, irregular nuclear membranes, nuclear grooves, sickles cells, psammoma bodies, and cystic changes. We evaluated the diagnostic performances of the cytomorphologic features to predict the BRAFV600E mutation. Polygonal eosinophilic (plump) cells, microfollicles, intranuclear pseudoinclusions, sickle cells, and cystic changes were significantly associated with the BRAFV600E mutation. The mutation was not present in all 6 thyroid nodules with microfollicles larger than 20% on cytology. Additionally, polygonal eosinophilic (plump) cells larger than 20%, cystic changes, and sickle cells on cytology had a high specificity of 95%, 96.7%, and 81.7%, respectively. Excluding 6 nodules with microfollicles larger than 20% on cytology, there were 82 (60.3%) nodules with the BRAFV600E mutation among the 136 nodules. Among the 136 nodules, there were 95 nodules with polygonal eosinophilic (plump) cells larger than 20%, cystic changes, or sickle cells on cytology. Of the 95 nodules, 69 (72.6%) had the mutation. Cytomorphologic features can help select nodules for the BRAFV600E mutation test among nodules read as "suspicious for malignancy" on cytology.

Original languageEnglish
Pages (from-to)671-676
Number of pages6
JournalPathology Research and Practice
Volume211
Issue number9
DOIs
Publication statusPublished - 2015 Sep 1

Fingerprint

Thyroid Nodule
Thyroid Neoplasms
Cell Biology
Mutation
Neoplasms
Nuclear Envelope

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

@article{5d3bb687582a43569adb88523a202fd3,
title = "Cytomorphologic features in thyroid nodules read as {"}suspicious for malignancy{"} on cytology may predict thyroid cancers with the BRAF mutation",
abstract = "Some morphologic parameters have been studied to help predict the BRAFV600E mutation using cytopathologic specimens, which can indicate which nodules should undergo further testing. The aim of this study was to investigate the value of cytomorphologic parameters to predict the BRAFV600E mutation in nodules read as {"}suspicious for malignancy{"} on cytology. This study included 142 resected nodules which were diagnosed as {"}suspicious for malignancy{"} on cytology in 142 patients. At our institution, BRAFV600E mutation analysis was performed at the request of the referring clinicians based on the clinical features of the patients, or the judgment of the radiologists performing US-FNA because suspicious US features were observed on the targeted nodule during this study period. Cytology smears were re-reviewed to assess the presence and amount of polygonal eosinophilic (plump) cells and microfollicles, and the presence of intranuclear pseudoinclusions, irregular nuclear membranes, nuclear grooves, sickles cells, psammoma bodies, and cystic changes. We evaluated the diagnostic performances of the cytomorphologic features to predict the BRAFV600E mutation. Polygonal eosinophilic (plump) cells, microfollicles, intranuclear pseudoinclusions, sickle cells, and cystic changes were significantly associated with the BRAFV600E mutation. The mutation was not present in all 6 thyroid nodules with microfollicles larger than 20{\%} on cytology. Additionally, polygonal eosinophilic (plump) cells larger than 20{\%}, cystic changes, and sickle cells on cytology had a high specificity of 95{\%}, 96.7{\%}, and 81.7{\%}, respectively. Excluding 6 nodules with microfollicles larger than 20{\%} on cytology, there were 82 (60.3{\%}) nodules with the BRAFV600E mutation among the 136 nodules. Among the 136 nodules, there were 95 nodules with polygonal eosinophilic (plump) cells larger than 20{\%}, cystic changes, or sickle cells on cytology. Of the 95 nodules, 69 (72.6{\%}) had the mutation. Cytomorphologic features can help select nodules for the BRAFV600E mutation test among nodules read as {"}suspicious for malignancy{"} on cytology.",
author = "Hyeongju Kwon and Eunkyung Kim and jinyoung kwak",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.prp.2015.06.010",
language = "English",
volume = "211",
pages = "671--676",
journal = "Pathology Research and Practice",
issn = "0344-0338",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "9",

}

TY - JOUR

T1 - Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation

AU - Kwon, Hyeongju

AU - Kim, Eunkyung

AU - kwak, jinyoung

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Some morphologic parameters have been studied to help predict the BRAFV600E mutation using cytopathologic specimens, which can indicate which nodules should undergo further testing. The aim of this study was to investigate the value of cytomorphologic parameters to predict the BRAFV600E mutation in nodules read as "suspicious for malignancy" on cytology. This study included 142 resected nodules which were diagnosed as "suspicious for malignancy" on cytology in 142 patients. At our institution, BRAFV600E mutation analysis was performed at the request of the referring clinicians based on the clinical features of the patients, or the judgment of the radiologists performing US-FNA because suspicious US features were observed on the targeted nodule during this study period. Cytology smears were re-reviewed to assess the presence and amount of polygonal eosinophilic (plump) cells and microfollicles, and the presence of intranuclear pseudoinclusions, irregular nuclear membranes, nuclear grooves, sickles cells, psammoma bodies, and cystic changes. We evaluated the diagnostic performances of the cytomorphologic features to predict the BRAFV600E mutation. Polygonal eosinophilic (plump) cells, microfollicles, intranuclear pseudoinclusions, sickle cells, and cystic changes were significantly associated with the BRAFV600E mutation. The mutation was not present in all 6 thyroid nodules with microfollicles larger than 20% on cytology. Additionally, polygonal eosinophilic (plump) cells larger than 20%, cystic changes, and sickle cells on cytology had a high specificity of 95%, 96.7%, and 81.7%, respectively. Excluding 6 nodules with microfollicles larger than 20% on cytology, there were 82 (60.3%) nodules with the BRAFV600E mutation among the 136 nodules. Among the 136 nodules, there were 95 nodules with polygonal eosinophilic (plump) cells larger than 20%, cystic changes, or sickle cells on cytology. Of the 95 nodules, 69 (72.6%) had the mutation. Cytomorphologic features can help select nodules for the BRAFV600E mutation test among nodules read as "suspicious for malignancy" on cytology.

AB - Some morphologic parameters have been studied to help predict the BRAFV600E mutation using cytopathologic specimens, which can indicate which nodules should undergo further testing. The aim of this study was to investigate the value of cytomorphologic parameters to predict the BRAFV600E mutation in nodules read as "suspicious for malignancy" on cytology. This study included 142 resected nodules which were diagnosed as "suspicious for malignancy" on cytology in 142 patients. At our institution, BRAFV600E mutation analysis was performed at the request of the referring clinicians based on the clinical features of the patients, or the judgment of the radiologists performing US-FNA because suspicious US features were observed on the targeted nodule during this study period. Cytology smears were re-reviewed to assess the presence and amount of polygonal eosinophilic (plump) cells and microfollicles, and the presence of intranuclear pseudoinclusions, irregular nuclear membranes, nuclear grooves, sickles cells, psammoma bodies, and cystic changes. We evaluated the diagnostic performances of the cytomorphologic features to predict the BRAFV600E mutation. Polygonal eosinophilic (plump) cells, microfollicles, intranuclear pseudoinclusions, sickle cells, and cystic changes were significantly associated with the BRAFV600E mutation. The mutation was not present in all 6 thyroid nodules with microfollicles larger than 20% on cytology. Additionally, polygonal eosinophilic (plump) cells larger than 20%, cystic changes, and sickle cells on cytology had a high specificity of 95%, 96.7%, and 81.7%, respectively. Excluding 6 nodules with microfollicles larger than 20% on cytology, there were 82 (60.3%) nodules with the BRAFV600E mutation among the 136 nodules. Among the 136 nodules, there were 95 nodules with polygonal eosinophilic (plump) cells larger than 20%, cystic changes, or sickle cells on cytology. Of the 95 nodules, 69 (72.6%) had the mutation. Cytomorphologic features can help select nodules for the BRAFV600E mutation test among nodules read as "suspicious for malignancy" on cytology.

UR - http://www.scopus.com/inward/record.url?scp=84940166561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940166561&partnerID=8YFLogxK

U2 - 10.1016/j.prp.2015.06.010

DO - 10.1016/j.prp.2015.06.010

M3 - Article

C2 - 26187369

AN - SCOPUS:84940166561

VL - 211

SP - 671

EP - 676

JO - Pathology Research and Practice

JF - Pathology Research and Practice

SN - 0344-0338

IS - 9

ER -